Biosynex
Designs and distributes medical diagnostic solutions, including rapid tests and devices.
ALBIO | PA
Overview
Corporate Details
- ISIN(s):
- FR0011005933
- LEI:
- 969500H4BGE1HBLGP566
- Country:
- France
- Address:
- 22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
- Website:
- https://www.biosynex.com/en/
- Sector:
- Manufacturing
Description
Biosynex is a company that specializes in the design, manufacture, and distribution of medical diagnostic solutions. Its core product line consists of Rapid Diagnostic Tests (RDTs) for both professional use in clinical settings and for self-testing by the general public. The professional portfolio includes point-of-care (POC) instruments, molecular biology diagnostics (such as PCR tests), and a wide array of immunodiagnostic assays. For the consumer market, Biosynex offers various self-tests and a range of prevention and monitoring devices, including thermometers, blood pressure monitors, and pulse oximeters. The company focuses on providing simple, rapid, and effective tools for screening, diagnosis, and prevention.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-05 18:00 |
BIOSYNEX SA: DÉCLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 MARS …
|
French | 286.5 KB | ||
| 2023-03-29 18:00 |
BIOSYNEX SA: PROLONGATION DE LA PERIODE D’OFFRE PUBLIQUE D’ACHAT SUR LES TITRES…
|
French | 605.7 KB | ||
| 2023-03-15 18:00 |
BIOSYNEX SA: PROLONGATION DE LA PERIODE D’OFFRE PUBLIQUE D’ACHAT SUR LES TITRES…
|
French | 273.3 KB | ||
| 2023-03-09 18:05 |
BIOSYNEX SA: ARRET DE LA COMMERCIALISATION DE BOUILLOTTES
|
French | 218.9 KB | ||
| 2023-02-08 08:00 |
BIOSYNEX SA: DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS
|
French | 285.4 KB | ||
| 2023-02-01 18:30 |
BIOSYNEX SA: ANNONCE DES RESULTATS DEFINITIFS DE L’OPA DE BIOSYNEX SUR LES ACT…
|
French | 675.0 KB | ||
| 2023-01-31 23:00 |
BIOSYNEX SA: BIOSYNEX ET CHEMBIO DIAGNOSTICS ANNONCENT UN ACCORD DEFINITIF D’A…
|
French | 259.0 KB | ||
| 2023-01-18 07:00 |
BIOSYNEX SA: REOUVERTURE DE L'OFFRE PUBLIQUE D'ACHAT VISANT LES ACTIONS THERADI…
|
French | 685.8 KB | ||
| 2023-01-16 18:12 |
BIOSYNEX SA: SUCCÈS DE L'OFFRE PUBLIQUE D'ACHAT INITIÉE PAR BIOSYNEX VISANT LE…
|
French | 678.5 KB | ||
| 2023-01-13 18:00 |
BIOSYNEX SA: Extension of the distribution agreement between Credo Diagnostics …
|
English | 304.5 KB | ||
| 2023-01-13 18:00 |
BIOSYNEX SA: Extension de l'accord de distribution entre Credo Diagnostics Biom…
|
French | 268.3 KB | ||
| 2022-12-21 18:00 |
BIOSYNEX SA: BIOSYNEX ANNONCE AVOIR PRIS UNE PARTICIPATION DE 75% DANS LA SO…
|
French | 324.0 KB | ||
| 2022-12-20 18:00 |
BIOSYNEX SA: Calendrier financier 2023
|
French | 291.1 KB | ||
| 2022-12-07 07:45 |
MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES AUTRES INFORMATIONS DE BIOSY…
|
French | 357.7 KB | ||
| 2022-11-08 18:00 |
BIOSYNEX : BIOSYNEX ANNONCE L’AUTORISATION 510(K) DE LA FDA POUR L’INSTRUMENT P…
|
French | 404.0 KB |
Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biosynex
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biosynex via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
